Cardiol Therapeutics Inc. (CRDL.TO)
CAD 1.58
(3.95%)
CAD 1.58
(3.95%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 158.53 Thousand CAD | 117.55% |
| 2022 | 72.87 Thousand CAD | -38.02% |
| 2021 | 117.57 Thousand CAD | -24.9% |
| 2020 | 156.56 Thousand CAD | -17.92% |
| 2019 | 190.75 Thousand CAD | -29.15% |
| 2018 | 269.21 Thousand CAD | 41.66% |
| 2017 | 190.04 Thousand CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 164.27 Thousand CAD | -1.71% |
| 2024 Q1 | 167.13 Thousand CAD | -4.13% |
| 2023 Q4 | 174.34 Thousand CAD | -3.79% |
| 2023 Q2 | 48.19 Thousand CAD | -20.55% |
| 2023 Q1 | 60.66 Thousand CAD | -16.75% |
| 2023 FY | 174.34 Thousand CAD | 139.24% |
| 2023 Q3 | 181.2 Thousand CAD | 275.99% |
| 2022 Q2 | 96.4 Thousand CAD | -10.1% |
| 2022 Q4 | 72.87 Thousand CAD | -14.04% |
| 2022 FY | 72.87 Thousand CAD | -38.02% |
| 2022 Q1 | 107.23 Thousand CAD | -8.79% |
| 2022 Q3 | 84.77 Thousand CAD | -12.07% |
| 2021 Q1 | 147.1 Thousand CAD | -6.05% |
| 2021 FY | 117.57 Thousand CAD | -24.9% |
| 2021 Q4 | 117.57 Thousand CAD | -7.88% |
| 2021 Q3 | 127.63 Thousand CAD | -7.15% |
| 2021 Q2 | 137.45 Thousand CAD | -6.55% |
| 2020 Q1 | 182.96 Thousand CAD | -4.08% |
| 2020 FY | 156.56 Thousand CAD | -17.92% |
| 2020 Q4 | 156.56 Thousand CAD | -5.54% |
| 2020 Q3 | 165.74 Thousand CAD | -5.14% |
| 2020 Q2 | 174.71 Thousand CAD | -4.51% |
| 2019 Q4 | 190.75 Thousand CAD | -3.82% |
| 2019 Q2 | 203.19 Thousand CAD | 0.0% |
| 2019 Q1 | - CAD | -100.0% |
| 2019 FY | 190.75 Thousand CAD | -29.15% |
| 2019 Q3 | 198.31 Thousand CAD | -2.4% |
| 2018 Q4 | 269.21 Thousand CAD | -97.86% |
| 2018 Q1 | - CAD | -100.0% |
| 2018 Q2 | 10.05 Million CAD | 0.0% |
| 2018 FY | 269.21 Thousand CAD | 41.66% |
| 2018 Q3 | 12.57 Million CAD | 25.13% |
| 2017 FY | 190.04 Thousand CAD | 0.0% |
| 2017 Q4 | 190.04 Thousand CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 104.79 Million CAD | 99.849% |
| Avicanna Inc. | 1.8 Million CAD | 91.209% |
| Avant Brands Inc. | 18.7 Million CAD | 99.152% |
| Crescita Therapeutics Inc. | 1.25 Million CAD | 87.358% |
| Knight Therapeutics Inc. | 69.09 Million CAD | 99.771% |
| MediPharm Labs Corp. | 2.29 Million CAD | 93.092% |
| OrganiGram Holdings Inc. | 155 Thousand CAD | -2.279% |
| Canopy Growth Corporation | 683.17 Million CAD | 99.977% |
| Willow Biosciences Inc. | 2.15 Million CAD | 92.647% |
| Auxly Cannabis Group Inc. | 159.04 Million CAD | 99.9% |